Global Cellular and Gene Therapy CDMO Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Cellular and Gene Therapy CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cellular and Gene Therapy CDMO.
The Cellular and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cellular and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular and Gene Therapy CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cellular and Gene Therapy CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cellular and Gene Therapy CDMO market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cellular and Gene Therapy CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Catalent
- Lonza
- Charles River
- The Discovery Labs
- BIOCENTRIQ
- FUJIFILM Diosynth Biotechnologies
- Exothera
- WuXi AppTec
- Pharmaron
- OBiO
- Cell Therapies
- AGC Biologics
- Cytiva
- Helixmith
- ThermoGenesis
- Anemocyte
- Thermo Fisher Scientific
- CBM
- Bio Elpida
- Genezen
- CCRM
- RoslinCT
- GenScript ProBio
- Oxford BioMedica
- Porton Pharma Solutions
- Cell Therapy
- Viral Vectors
- Plasmid
- Commercial
- Academic Research
- Others
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cellular and Gene Therapy CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 HETEROCYCLIC DISPERSE DYES MARKET OVERVIEW
1.1 Product Definition
1.2 Heterocyclic Disperse Dyes Segment by Type
1.2.1 Global Heterocyclic Disperse Dyes Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Bright Color
1.2.3 Dark Color
1.3 Heterocyclic Disperse Dyes Segment by Application
1.3.1 Global Heterocyclic Disperse Dyes Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Textile
1.3.3 Plastics
1.3.4 Printing Ink
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Heterocyclic Disperse Dyes Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Heterocyclic Disperse Dyes Production Estimates and Forecasts (2018-2029)
1.4.4 Global Heterocyclic Disperse Dyes Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Heterocyclic Disperse Dyes Production Market Share by Manufacturers (2018-2023)
2.2 Global Heterocyclic Disperse Dyes Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Heterocyclic Disperse Dyes, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Heterocyclic Disperse Dyes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Heterocyclic Disperse Dyes Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Heterocyclic Disperse Dyes, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Heterocyclic Disperse Dyes, Product Offered and Application
2.8 Global Key Manufacturers of Heterocyclic Disperse Dyes, Date of Enter into This Industry
2.9 Heterocyclic Disperse Dyes Market Competitive Situation and Trends
2.9.1 Heterocyclic Disperse Dyes Market Concentration Rate
2.9.2 Global 5 and 10 Largest Heterocyclic Disperse Dyes Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 HETEROCYCLIC DISPERSE DYES PRODUCTION BY REGION
3.1 Global Heterocyclic Disperse Dyes Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Heterocyclic Disperse Dyes Production Value by Region (2018-2029)
3.2.1 Global Heterocyclic Disperse Dyes Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Heterocyclic Disperse Dyes by Region (2024-2029)
3.3 Global Heterocyclic Disperse Dyes Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Heterocyclic Disperse Dyes Production by Region (2018-2029)
3.4.1 Global Heterocyclic Disperse Dyes Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Heterocyclic Disperse Dyes by Region (2024-2029)
3.5 Global Heterocyclic Disperse Dyes Market Price Analysis by Region (2018-2023)
3.6 Global Heterocyclic Disperse Dyes Production and Value, Year-over-Year Growth
3.6.1 North America Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
4 HETEROCYCLIC DISPERSE DYES CONSUMPTION BY REGION
4.1 Global Heterocyclic Disperse Dyes Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Heterocyclic Disperse Dyes Consumption by Region (2018-2029)
4.2.1 Global Heterocyclic Disperse Dyes Consumption by Region (2018-2023)
4.2.2 Global Heterocyclic Disperse Dyes Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Heterocyclic Disperse Dyes Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Heterocyclic Disperse Dyes Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 SEGMENT BY TYPE
5.1 Global Heterocyclic Disperse Dyes Production by Type (2018-2029)
5.1.1 Global Heterocyclic Disperse Dyes Production by Type (2018-2023)
5.1.2 Global Heterocyclic Disperse Dyes Production by Type (2024-2029)
5.1.3 Global Heterocyclic Disperse Dyes Production Market Share by Type (2018-2029)
5.2 Global Heterocyclic Disperse Dyes Production Value by Type (2018-2029)
5.2.1 Global Heterocyclic Disperse Dyes Production Value by Type (2018-2023)
5.2.2 Global Heterocyclic Disperse Dyes Production Value by Type (2024-2029)
5.2.3 Global Heterocyclic Disperse Dyes Production Value Market Share by Type (2018-2029)
5.3 Global Heterocyclic Disperse Dyes Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Heterocyclic Disperse Dyes Production by Application (2018-2029)
6.1.1 Global Heterocyclic Disperse Dyes Production by Application (2018-2023)
6.1.2 Global Heterocyclic Disperse Dyes Production by Application (2024-2029)
6.1.3 Global Heterocyclic Disperse Dyes Production Market Share by Application (2018-2029)
6.2 Global Heterocyclic Disperse Dyes Production Value by Application (2018-2029)
6.2.1 Global Heterocyclic Disperse Dyes Production Value by Application (2018-2023)
6.2.2 Global Heterocyclic Disperse Dyes Production Value by Application (2024-2029)
6.2.3 Global Heterocyclic Disperse Dyes Production Value Market Share by Application (2018-2029)
6.3 Global Heterocyclic Disperse Dyes Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Dystar
7.1.1 Dystar Heterocyclic Disperse Dyes Corporation Information
7.1.2 Dystar Heterocyclic Disperse Dyes Product Portfolio
7.1.3 Dystar Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dystar Main Business and Markets Served
7.1.5 Dystar Recent Developments/Updates
7.2 HUNTSMAN
7.2.1 HUNTSMAN Heterocyclic Disperse Dyes Corporation Information
7.2.2 HUNTSMAN Heterocyclic Disperse Dyes Product Portfolio
7.2.3 HUNTSMAN Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.2.4 HUNTSMAN Main Business and Markets Served
7.2.5 HUNTSMAN Recent Developments/Updates
7.3 Archroma
7.3.1 Archroma Heterocyclic Disperse Dyes Corporation Information
7.3.2 Archroma Heterocyclic Disperse Dyes Product Portfolio
7.3.3 Archroma Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Archroma Main Business and Markets Served
7.3.5 Archroma Recent Developments/Updates
7.4 BASF
7.4.1 BASF Heterocyclic Disperse Dyes Corporation Information
7.4.2 BASF Heterocyclic Disperse Dyes Product Portfolio
7.4.3 BASF Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.4.4 BASF Main Business and Markets Served
7.4.5 BASF Recent Developments/Updates
7.5 Clariant
7.5.1 Clariant Heterocyclic Disperse Dyes Corporation Information
7.5.2 Clariant Heterocyclic Disperse Dyes Product Portfolio
7.5.3 Clariant Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Clariant Main Business and Markets Served
7.5.5 Clariant Recent Developments/Updates
7.6 Akik Dye Chem
7.6.1 Akik Dye Chem Heterocyclic Disperse Dyes Corporation Information
7.6.2 Akik Dye Chem Heterocyclic Disperse Dyes Product Portfolio
7.6.3 Akik Dye Chem Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Akik Dye Chem Main Business and Markets Served
7.6.5 Akik Dye Chem Recent Developments/Updates
7.7 Yorkshire
7.7.1 Yorkshire Heterocyclic Disperse Dyes Corporation Information
7.7.2 Yorkshire Heterocyclic Disperse Dyes Product Portfolio
7.7.3 Yorkshire Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Yorkshire Main Business and Markets Served
7.7.5 Yorkshire Recent Developments/Updates
7.8 Zhejiang Longsheng Group
7.8.1 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Corporation Information
7.8.2 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Product Portfolio
7.8.3 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Zhejiang Longsheng Group Main Business and Markets Served
7.7.5 Zhejiang Longsheng Group Recent Developments/Updates
7.9 Zhejiang Runtu
7.9.1 Zhejiang Runtu Heterocyclic Disperse Dyes Corporation Information
7.9.2 Zhejiang Runtu Heterocyclic Disperse Dyes Product Portfolio
7.9.3 Zhejiang Runtu Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhejiang Runtu Main Business and Markets Served
7.9.5 Zhejiang Runtu Recent Developments/Updates
7.10 ZheJiang JiHua Group
7.10.1 ZheJiang JiHua Group Heterocyclic Disperse Dyes Corporation Information
7.10.2 ZheJiang JiHua Group Heterocyclic Disperse Dyes Product Portfolio
7.10.3 ZheJiang JiHua Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.10.4 ZheJiang JiHua Group Main Business and Markets Served
7.10.5 ZheJiang JiHua Group Recent Developments/Updates
7.11 Shanghai Anoky Group
7.11.1 Shanghai Anoky Group Heterocyclic Disperse Dyes Corporation Information
7.11.2 Shanghai Anoky Group Heterocyclic Disperse Dyes Product Portfolio
7.11.3 Shanghai Anoky Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Shanghai Anoky Group Main Business and Markets Served
7.11.5 Shanghai Anoky Group Recent Developments/Updates
7.12 Hangzhou Flariant
7.12.1 Hangzhou Flariant Heterocyclic Disperse Dyes Corporation Information
7.12.2 Hangzhou Flariant Heterocyclic Disperse Dyes Product Portfolio
7.12.3 Hangzhou Flariant Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Hangzhou Flariant Main Business and Markets Served
7.12.5 Hangzhou Flariant Recent Developments/Updates
7.13 Zhejiang BOAO New Material
7.13.1 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Corporation Information
7.13.2 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Product Portfolio
7.13.3 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Zhejiang BOAO New Material Main Business and Markets Served
7.13.5 Zhejiang BOAO New Material Recent Developments/Updates
7.14 Zhejiang Wanfeng Chemical
7.14.1 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Corporation Information
7.14.2 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Product Portfolio
7.14.3 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Zhejiang Wanfeng Chemical Main Business and Markets Served
7.14.5 Zhejiang Wanfeng Chemical Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Heterocyclic Disperse Dyes Industry Chain Analysis
8.2 Heterocyclic Disperse Dyes Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Heterocyclic Disperse Dyes Production Mode & Process
8.4 Heterocyclic Disperse Dyes Sales and Marketing
8.4.1 Heterocyclic Disperse Dyes Sales Channels
8.4.2 Heterocyclic Disperse Dyes Distributors
8.5 Heterocyclic Disperse Dyes Customers
9 HETEROCYCLIC DISPERSE DYES MARKET DYNAMICS
9.1 Heterocyclic Disperse Dyes Industry Trends
9.2 Heterocyclic Disperse Dyes Market Drivers
9.3 Heterocyclic Disperse Dyes Market Challenges
9.4 Heterocyclic Disperse Dyes Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Heterocyclic Disperse Dyes Segment by Type
1.2.1 Global Heterocyclic Disperse Dyes Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Bright Color
1.2.3 Dark Color
1.3 Heterocyclic Disperse Dyes Segment by Application
1.3.1 Global Heterocyclic Disperse Dyes Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Textile
1.3.3 Plastics
1.3.4 Printing Ink
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Heterocyclic Disperse Dyes Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Heterocyclic Disperse Dyes Production Estimates and Forecasts (2018-2029)
1.4.4 Global Heterocyclic Disperse Dyes Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 MARKET COMPETITION BY MANUFACTURERS
2.1 Global Heterocyclic Disperse Dyes Production Market Share by Manufacturers (2018-2023)
2.2 Global Heterocyclic Disperse Dyes Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Heterocyclic Disperse Dyes, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Heterocyclic Disperse Dyes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Heterocyclic Disperse Dyes Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Heterocyclic Disperse Dyes, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Heterocyclic Disperse Dyes, Product Offered and Application
2.8 Global Key Manufacturers of Heterocyclic Disperse Dyes, Date of Enter into This Industry
2.9 Heterocyclic Disperse Dyes Market Competitive Situation and Trends
2.9.1 Heterocyclic Disperse Dyes Market Concentration Rate
2.9.2 Global 5 and 10 Largest Heterocyclic Disperse Dyes Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 HETEROCYCLIC DISPERSE DYES PRODUCTION BY REGION
3.1 Global Heterocyclic Disperse Dyes Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Heterocyclic Disperse Dyes Production Value by Region (2018-2029)
3.2.1 Global Heterocyclic Disperse Dyes Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Heterocyclic Disperse Dyes by Region (2024-2029)
3.3 Global Heterocyclic Disperse Dyes Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Heterocyclic Disperse Dyes Production by Region (2018-2029)
3.4.1 Global Heterocyclic Disperse Dyes Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Heterocyclic Disperse Dyes by Region (2024-2029)
3.5 Global Heterocyclic Disperse Dyes Market Price Analysis by Region (2018-2023)
3.6 Global Heterocyclic Disperse Dyes Production and Value, Year-over-Year Growth
3.6.1 North America Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Heterocyclic Disperse Dyes Production Value Estimates and Forecasts (2018-2029)
4 HETEROCYCLIC DISPERSE DYES CONSUMPTION BY REGION
4.1 Global Heterocyclic Disperse Dyes Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Heterocyclic Disperse Dyes Consumption by Region (2018-2029)
4.2.1 Global Heterocyclic Disperse Dyes Consumption by Region (2018-2023)
4.2.2 Global Heterocyclic Disperse Dyes Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Heterocyclic Disperse Dyes Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Heterocyclic Disperse Dyes Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Heterocyclic Disperse Dyes Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Heterocyclic Disperse Dyes Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 SEGMENT BY TYPE
5.1 Global Heterocyclic Disperse Dyes Production by Type (2018-2029)
5.1.1 Global Heterocyclic Disperse Dyes Production by Type (2018-2023)
5.1.2 Global Heterocyclic Disperse Dyes Production by Type (2024-2029)
5.1.3 Global Heterocyclic Disperse Dyes Production Market Share by Type (2018-2029)
5.2 Global Heterocyclic Disperse Dyes Production Value by Type (2018-2029)
5.2.1 Global Heterocyclic Disperse Dyes Production Value by Type (2018-2023)
5.2.2 Global Heterocyclic Disperse Dyes Production Value by Type (2024-2029)
5.2.3 Global Heterocyclic Disperse Dyes Production Value Market Share by Type (2018-2029)
5.3 Global Heterocyclic Disperse Dyes Price by Type (2018-2029)
6 SEGMENT BY APPLICATION
6.1 Global Heterocyclic Disperse Dyes Production by Application (2018-2029)
6.1.1 Global Heterocyclic Disperse Dyes Production by Application (2018-2023)
6.1.2 Global Heterocyclic Disperse Dyes Production by Application (2024-2029)
6.1.3 Global Heterocyclic Disperse Dyes Production Market Share by Application (2018-2029)
6.2 Global Heterocyclic Disperse Dyes Production Value by Application (2018-2029)
6.2.1 Global Heterocyclic Disperse Dyes Production Value by Application (2018-2023)
6.2.2 Global Heterocyclic Disperse Dyes Production Value by Application (2024-2029)
6.2.3 Global Heterocyclic Disperse Dyes Production Value Market Share by Application (2018-2029)
6.3 Global Heterocyclic Disperse Dyes Price by Application (2018-2029)
7 KEY COMPANIES PROFILED
7.1 Dystar
7.1.1 Dystar Heterocyclic Disperse Dyes Corporation Information
7.1.2 Dystar Heterocyclic Disperse Dyes Product Portfolio
7.1.3 Dystar Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dystar Main Business and Markets Served
7.1.5 Dystar Recent Developments/Updates
7.2 HUNTSMAN
7.2.1 HUNTSMAN Heterocyclic Disperse Dyes Corporation Information
7.2.2 HUNTSMAN Heterocyclic Disperse Dyes Product Portfolio
7.2.3 HUNTSMAN Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.2.4 HUNTSMAN Main Business and Markets Served
7.2.5 HUNTSMAN Recent Developments/Updates
7.3 Archroma
7.3.1 Archroma Heterocyclic Disperse Dyes Corporation Information
7.3.2 Archroma Heterocyclic Disperse Dyes Product Portfolio
7.3.3 Archroma Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Archroma Main Business and Markets Served
7.3.5 Archroma Recent Developments/Updates
7.4 BASF
7.4.1 BASF Heterocyclic Disperse Dyes Corporation Information
7.4.2 BASF Heterocyclic Disperse Dyes Product Portfolio
7.4.3 BASF Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.4.4 BASF Main Business and Markets Served
7.4.5 BASF Recent Developments/Updates
7.5 Clariant
7.5.1 Clariant Heterocyclic Disperse Dyes Corporation Information
7.5.2 Clariant Heterocyclic Disperse Dyes Product Portfolio
7.5.3 Clariant Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Clariant Main Business and Markets Served
7.5.5 Clariant Recent Developments/Updates
7.6 Akik Dye Chem
7.6.1 Akik Dye Chem Heterocyclic Disperse Dyes Corporation Information
7.6.2 Akik Dye Chem Heterocyclic Disperse Dyes Product Portfolio
7.6.3 Akik Dye Chem Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Akik Dye Chem Main Business and Markets Served
7.6.5 Akik Dye Chem Recent Developments/Updates
7.7 Yorkshire
7.7.1 Yorkshire Heterocyclic Disperse Dyes Corporation Information
7.7.2 Yorkshire Heterocyclic Disperse Dyes Product Portfolio
7.7.3 Yorkshire Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Yorkshire Main Business and Markets Served
7.7.5 Yorkshire Recent Developments/Updates
7.8 Zhejiang Longsheng Group
7.8.1 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Corporation Information
7.8.2 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Product Portfolio
7.8.3 Zhejiang Longsheng Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Zhejiang Longsheng Group Main Business and Markets Served
7.7.5 Zhejiang Longsheng Group Recent Developments/Updates
7.9 Zhejiang Runtu
7.9.1 Zhejiang Runtu Heterocyclic Disperse Dyes Corporation Information
7.9.2 Zhejiang Runtu Heterocyclic Disperse Dyes Product Portfolio
7.9.3 Zhejiang Runtu Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Zhejiang Runtu Main Business and Markets Served
7.9.5 Zhejiang Runtu Recent Developments/Updates
7.10 ZheJiang JiHua Group
7.10.1 ZheJiang JiHua Group Heterocyclic Disperse Dyes Corporation Information
7.10.2 ZheJiang JiHua Group Heterocyclic Disperse Dyes Product Portfolio
7.10.3 ZheJiang JiHua Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.10.4 ZheJiang JiHua Group Main Business and Markets Served
7.10.5 ZheJiang JiHua Group Recent Developments/Updates
7.11 Shanghai Anoky Group
7.11.1 Shanghai Anoky Group Heterocyclic Disperse Dyes Corporation Information
7.11.2 Shanghai Anoky Group Heterocyclic Disperse Dyes Product Portfolio
7.11.3 Shanghai Anoky Group Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Shanghai Anoky Group Main Business and Markets Served
7.11.5 Shanghai Anoky Group Recent Developments/Updates
7.12 Hangzhou Flariant
7.12.1 Hangzhou Flariant Heterocyclic Disperse Dyes Corporation Information
7.12.2 Hangzhou Flariant Heterocyclic Disperse Dyes Product Portfolio
7.12.3 Hangzhou Flariant Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Hangzhou Flariant Main Business and Markets Served
7.12.5 Hangzhou Flariant Recent Developments/Updates
7.13 Zhejiang BOAO New Material
7.13.1 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Corporation Information
7.13.2 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Product Portfolio
7.13.3 Zhejiang BOAO New Material Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Zhejiang BOAO New Material Main Business and Markets Served
7.13.5 Zhejiang BOAO New Material Recent Developments/Updates
7.14 Zhejiang Wanfeng Chemical
7.14.1 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Corporation Information
7.14.2 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Product Portfolio
7.14.3 Zhejiang Wanfeng Chemical Heterocyclic Disperse Dyes Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Zhejiang Wanfeng Chemical Main Business and Markets Served
7.14.5 Zhejiang Wanfeng Chemical Recent Developments/Updates
8 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Heterocyclic Disperse Dyes Industry Chain Analysis
8.2 Heterocyclic Disperse Dyes Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Heterocyclic Disperse Dyes Production Mode & Process
8.4 Heterocyclic Disperse Dyes Sales and Marketing
8.4.1 Heterocyclic Disperse Dyes Sales Channels
8.4.2 Heterocyclic Disperse Dyes Distributors
8.5 Heterocyclic Disperse Dyes Customers
9 HETEROCYCLIC DISPERSE DYES MARKET DYNAMICS
9.1 Heterocyclic Disperse Dyes Industry Trends
9.2 Heterocyclic Disperse Dyes Market Drivers
9.3 Heterocyclic Disperse Dyes Market Challenges
9.4 Heterocyclic Disperse Dyes Market Restraints
10 RESEARCH FINDING AND CONCLUSION
11 METHODOLOGY AND DATA SOURCE
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
LIST OF TABLES
Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Viral Vectors
Table 4. Key Players of Plasmid
Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2018-2023)
Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2024-2029)
Table 11. Cellular and Gene Therapy CDMO Market Trends
Table 12. Cellular and Gene Therapy CDMO Market Drivers
Table 13. Cellular and Gene Therapy CDMO Market Challenges
Table 14. Cellular and Gene Therapy CDMO Market Restraints
Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2018-2023)
Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cellular and Gene Therapy CDMO Product Solution and Service
Table 22. Date of Enter into Cellular and Gene Therapy CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2024-2029)
Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2018-2023)
Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2024-2029)
Table 32. North America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Cellular and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 47. Catalent Company Detail
Table 48. Catalent Business Overview
Table 49. Catalent Cellular and Gene Therapy CDMO Product
Table 50. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. Lonza Company Detail
Table 53. Lonza Business Overview
Table 54. Lonza Cellular and Gene Therapy CDMO Product
Table 55. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 56. Lonza Recent Development
Table 57. Charles River Company Detail
Table 58. Charles River Business Overview
Table 59. Charles River Cellular and Gene Therapy CDMO Product
Table 60. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 61. Charles River Recent Development
Table 62. The Discovery Labs Company Detail
Table 63. The Discovery Labs Business Overview
Table 64. The Discovery Labs Cellular and Gene Therapy CDMO Product
Table 65. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 66. The Discovery Labs Recent Development
Table 67. BIOCENTRIQ Company Detail
Table 68. BIOCENTRIQ Business Overview
Table 69. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
Table 70. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 71. BIOCENTRIQ Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Detail
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. Exothera Company Detail
Table 78. Exothera Business Overview
Table 79. Exothera Cellular and Gene Therapy CDMO Product
Table 80. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 81. Exothera Recent Development
Table 82. WuXi AppTec Company Detail
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Cellular and Gene Therapy CDMO Product
Table 85. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 86. WuXi AppTec Recent Development
Table 87. Pharmaron Company Detail
Table 88. Pharmaron Business Overview
Table 89. Pharmaron Cellular and Gene Therapy CDMO Product
Table 90. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 91. Pharmaron Recent Development
Table 92. OBiO Company Detail
Table 93. OBiO Business Overview
Table 94. OBiO Cellular and Gene Therapy CDMO Product
Table 95. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 96. OBiO Recent Development
Table 97. Cell Therapies Company Detail
Table 98. Cell Therapies Business Overview
Table 99. Cell Therapies Cellular and Gene Therapy CDMO Product
Table 100. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 101. Cell Therapies Recent Development
Table 102. AGC Biologics Company Detail
Table 103. AGC Biologics Business Overview
Table 104. AGC Biologics Cellular and Gene Therapy CDMO Product
Table 105. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 106. AGC Biologics Recent Development
Table 107. Cytiva Company Detail
Table 108. Cytiva Business Overview
Table 109. Cytiva Cellular and Gene Therapy CDMO Product
Table 110. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 111. Cytiva Recent Development
Table 112. Helixmith Company Detail
Table 113. Helixmith Business Overview
Table 114. Helixmith Cellular and Gene Therapy CDMO Product
Table 115. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 116. Helixmith Recent Development
Table 117. ThermoGenesis Company Detail
Table 118. ThermoGenesis Business Overview
Table 119. ThermoGenesis Cellular and Gene Therapy CDMO Product
Table 120. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 121. ThermoGenesis Recent Development
Table 122. Anemocyte Company Detail
Table 123. Anemocyte Business Overview
Table 124. Anemocyte Cellular and Gene Therapy CDMO Product
Table 125. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 126. Anemocyte Recent Development
Table 127. Thermo Fisher Scientific Company Detail
Table 128. Thermo Fisher Scientific Business Overview
Table 129. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product
Table 130. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 131. Thermo Fisher Scientific Recent Development
Table 132. CBM Company Detail
Table 133. CBM Business Overview
Table 134. CBM Cellular and Gene Therapy CDMO Product
Table 135. CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 136. CBM Recent Development
Table 137. Bio Elpida Company Detail
Table 138. Bio Elpida Business Overview
Table 139. Bio Elpida Cellular and Gene Therapy CDMO Product
Table 140. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 141. Bio Elpida Recent Development
Table 142. Genezen Company Detail
Table 143. Genezen Business Overview
Table 144. Genezen Cellular and Gene Therapy CDMO Product
Table 145. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 146. Genezen Recent Development
Table 147. CCRM Company Detail
Table 148. CCRM Business Overview
Table 149. CCRM Cellular and Gene Therapy CDMO Product
Table 150. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 151. CCRM Recent Development
Table 152. RoslinCT Company Detail
Table 153. RoslinCT Business Overview
Table 154. RoslinCT Cellular and Gene Therapy CDMO Product
Table 155. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 156. RoslinCT Recent Development
Table 157. GenScript ProBio Company Detail
Table 158. GenScript ProBio Business Overview
Table 159. GenScript ProBio Cellular and Gene Therapy CDMO Product
Table 160. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 161. GenScript ProBio Recent Development
Table 162. Oxford BioMedica Company Detail
Table 163. Oxford BioMedica Business Overview
Table 164. Oxford BioMedica Cellular and Gene Therapy CDMO Product
Table 165. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 166. Oxford BioMedica Recent Development
Table 167. Porton Pharma Solutions Company Detail
Table 168. Porton Pharma Solutions Business Overview
Table 169. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product
Table 170. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 171. Porton Pharma Solutions Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
Table 1. Global Cellular and Gene Therapy CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Viral Vectors
Table 4. Key Players of Plasmid
Table 5. Global Cellular and Gene Therapy CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Cellular and Gene Therapy CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cellular and Gene Therapy CDMO Market Share by Region (2018-2023)
Table 9. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cellular and Gene Therapy CDMO Market Share by Region (2024-2029)
Table 11. Cellular and Gene Therapy CDMO Market Trends
Table 12. Cellular and Gene Therapy CDMO Market Drivers
Table 13. Cellular and Gene Therapy CDMO Market Challenges
Table 14. Cellular and Gene Therapy CDMO Market Restraints
Table 15. Global Cellular and Gene Therapy CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cellular and Gene Therapy CDMO Market Share by Players (2018-2023)
Table 17. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Table 18. Ranking of Global Top Cellular and Gene Therapy CDMO Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cellular and Gene Therapy CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cellular and Gene Therapy CDMO Product Solution and Service
Table 22. Date of Enter into Cellular and Gene Therapy CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cellular and Gene Therapy CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cellular and Gene Therapy CDMO Revenue Market Share by Type (2024-2029)
Table 28. Global Cellular and Gene Therapy CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2018-2023)
Table 30. Global Cellular and Gene Therapy CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cellular and Gene Therapy CDMO Revenue Market Share by Application (2024-2029)
Table 32. North America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Cellular and Gene Therapy CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cellular and Gene Therapy CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Cellular and Gene Therapy CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cellular and Gene Therapy CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 47. Catalent Company Detail
Table 48. Catalent Business Overview
Table 49. Catalent Cellular and Gene Therapy CDMO Product
Table 50. Catalent Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. Lonza Company Detail
Table 53. Lonza Business Overview
Table 54. Lonza Cellular and Gene Therapy CDMO Product
Table 55. Lonza Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 56. Lonza Recent Development
Table 57. Charles River Company Detail
Table 58. Charles River Business Overview
Table 59. Charles River Cellular and Gene Therapy CDMO Product
Table 60. Charles River Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 61. Charles River Recent Development
Table 62. The Discovery Labs Company Detail
Table 63. The Discovery Labs Business Overview
Table 64. The Discovery Labs Cellular and Gene Therapy CDMO Product
Table 65. The Discovery Labs Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 66. The Discovery Labs Recent Development
Table 67. BIOCENTRIQ Company Detail
Table 68. BIOCENTRIQ Business Overview
Table 69. BIOCENTRIQ Cellular and Gene Therapy CDMO Product
Table 70. BIOCENTRIQ Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 71. BIOCENTRIQ Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Detail
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Cellular and Gene Therapy CDMO Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. Exothera Company Detail
Table 78. Exothera Business Overview
Table 79. Exothera Cellular and Gene Therapy CDMO Product
Table 80. Exothera Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 81. Exothera Recent Development
Table 82. WuXi AppTec Company Detail
Table 83. WuXi AppTec Business Overview
Table 84. WuXi AppTec Cellular and Gene Therapy CDMO Product
Table 85. WuXi AppTec Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 86. WuXi AppTec Recent Development
Table 87. Pharmaron Company Detail
Table 88. Pharmaron Business Overview
Table 89. Pharmaron Cellular and Gene Therapy CDMO Product
Table 90. Pharmaron Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 91. Pharmaron Recent Development
Table 92. OBiO Company Detail
Table 93. OBiO Business Overview
Table 94. OBiO Cellular and Gene Therapy CDMO Product
Table 95. OBiO Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 96. OBiO Recent Development
Table 97. Cell Therapies Company Detail
Table 98. Cell Therapies Business Overview
Table 99. Cell Therapies Cellular and Gene Therapy CDMO Product
Table 100. Cell Therapies Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 101. Cell Therapies Recent Development
Table 102. AGC Biologics Company Detail
Table 103. AGC Biologics Business Overview
Table 104. AGC Biologics Cellular and Gene Therapy CDMO Product
Table 105. AGC Biologics Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 106. AGC Biologics Recent Development
Table 107. Cytiva Company Detail
Table 108. Cytiva Business Overview
Table 109. Cytiva Cellular and Gene Therapy CDMO Product
Table 110. Cytiva Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 111. Cytiva Recent Development
Table 112. Helixmith Company Detail
Table 113. Helixmith Business Overview
Table 114. Helixmith Cellular and Gene Therapy CDMO Product
Table 115. Helixmith Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 116. Helixmith Recent Development
Table 117. ThermoGenesis Company Detail
Table 118. ThermoGenesis Business Overview
Table 119. ThermoGenesis Cellular and Gene Therapy CDMO Product
Table 120. ThermoGenesis Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 121. ThermoGenesis Recent Development
Table 122. Anemocyte Company Detail
Table 123. Anemocyte Business Overview
Table 124. Anemocyte Cellular and Gene Therapy CDMO Product
Table 125. Anemocyte Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 126. Anemocyte Recent Development
Table 127. Thermo Fisher Scientific Company Detail
Table 128. Thermo Fisher Scientific Business Overview
Table 129. Thermo Fisher Scientific Cellular and Gene Therapy CDMO Product
Table 130. Thermo Fisher Scientific Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 131. Thermo Fisher Scientific Recent Development
Table 132. CBM Company Detail
Table 133. CBM Business Overview
Table 134. CBM Cellular and Gene Therapy CDMO Product
Table 135. CBM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 136. CBM Recent Development
Table 137. Bio Elpida Company Detail
Table 138. Bio Elpida Business Overview
Table 139. Bio Elpida Cellular and Gene Therapy CDMO Product
Table 140. Bio Elpida Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 141. Bio Elpida Recent Development
Table 142. Genezen Company Detail
Table 143. Genezen Business Overview
Table 144. Genezen Cellular and Gene Therapy CDMO Product
Table 145. Genezen Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 146. Genezen Recent Development
Table 147. CCRM Company Detail
Table 148. CCRM Business Overview
Table 149. CCRM Cellular and Gene Therapy CDMO Product
Table 150. CCRM Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 151. CCRM Recent Development
Table 152. RoslinCT Company Detail
Table 153. RoslinCT Business Overview
Table 154. RoslinCT Cellular and Gene Therapy CDMO Product
Table 155. RoslinCT Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 156. RoslinCT Recent Development
Table 157. GenScript ProBio Company Detail
Table 158. GenScript ProBio Business Overview
Table 159. GenScript ProBio Cellular and Gene Therapy CDMO Product
Table 160. GenScript ProBio Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 161. GenScript ProBio Recent Development
Table 162. Oxford BioMedica Company Detail
Table 163. Oxford BioMedica Business Overview
Table 164. Oxford BioMedica Cellular and Gene Therapy CDMO Product
Table 165. Oxford BioMedica Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 166. Oxford BioMedica Recent Development
Table 167. Porton Pharma Solutions Company Detail
Table 168. Porton Pharma Solutions Business Overview
Table 169. Porton Pharma Solutions Cellular and Gene Therapy CDMO Product
Table 170. Porton Pharma Solutions Revenue in Cellular and Gene Therapy CDMO Business (2018-2023) & (US$ Million)
Table 171. Porton Pharma Solutions Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Cellular and Gene Therapy CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cellular and Gene Therapy CDMO Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy Features
Figure 4. Viral Vectors Features
Figure 5. Plasmid Features
Figure 6. Global Cellular and Gene Therapy CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Cellular and Gene Therapy CDMO Market Share by Application: 2022 VS 2029
Figure 8. Commercial Case Studies
Figure 9. Academic Research Case Studies
Figure 10. Others Case Studies
Figure 11. Cellular and Gene Therapy CDMO Report Years Considered
Figure 12. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cellular and Gene Therapy CDMO Market Share by Region: 2022 VS 2029
Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Players in 2022
Figure 16. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 18. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 20. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 24. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2018-2029)
Figure 32. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 40. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 44. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 47. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 48. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 49. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 50. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 52. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 53. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 54. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 55. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 56. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 57. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 58. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 59. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 60. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 61. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 63. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 64. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 65. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 66. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 67. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 68. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 69. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 70. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Figure 1. Global Cellular and Gene Therapy CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Cellular and Gene Therapy CDMO Market Share by Type: 2022 VS 2029
Figure 3. Cell Therapy Features
Figure 4. Viral Vectors Features
Figure 5. Plasmid Features
Figure 6. Global Cellular and Gene Therapy CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Cellular and Gene Therapy CDMO Market Share by Application: 2022 VS 2029
Figure 8. Commercial Case Studies
Figure 9. Academic Research Case Studies
Figure 10. Others Case Studies
Figure 11. Cellular and Gene Therapy CDMO Report Years Considered
Figure 12. Global Cellular and Gene Therapy CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cellular and Gene Therapy CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cellular and Gene Therapy CDMO Market Share by Region: 2022 VS 2029
Figure 15. Global Cellular and Gene Therapy CDMO Market Share by Players in 2022
Figure 16. Global Top Cellular and Gene Therapy CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy CDMO as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cellular and Gene Therapy CDMO Revenue in 2022
Figure 18. North America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 20. United States Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 24. Germany Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Cellular and Gene Therapy CDMO Market Share by Region (2018-2029)
Figure 32. China Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 40. Mexico Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Cellular and Gene Therapy CDMO Market Share by Country (2018-2029)
Figure 44. Turkey Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Cellular and Gene Therapy CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Catalent Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 47. Lonza Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 48. Charles River Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 49. The Discovery Labs Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 50. BIOCENTRIQ Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 52. Exothera Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 53. WuXi AppTec Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 54. Pharmaron Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 55. OBiO Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 56. Cell Therapies Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 57. AGC Biologics Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 58. Cytiva Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 59. Helixmith Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 60. ThermoGenesis Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 61. Anemocyte Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 63. CBM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 64. Bio Elpida Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 65. Genezen Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 66. CCRM Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 67. RoslinCT Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 68. GenScript ProBio Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 69. Oxford BioMedica Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 70. Porton Pharma Solutions Revenue Growth Rate in Cellular and Gene Therapy CDMO Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
